LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression

Weitao Yao1, Jingyu Hou1, Guoqing Liu1

  • 1Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China.

Abstract

Insights

Long non-coding RNA STK4 antisense RNA 1 (STK4-AS1) promotes osteosarcoma cell proliferation by inhibiting p53 expression, impacting cell cycle progression. This finding highlights STK4-AS1 as a potential therapeutic target for osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNA STK4 antisense RNA 1 (STK4-AS1) is implicated as a potential biomarker in various cancers.
  • This study investigates the role of STK4-AS1 in osteosarcoma proliferation, specifically its regulation of the cell cycle.

Purpose of the Study:

  • To determine the expression levels of STK4-AS1, p53, and p21 in osteosarcoma compared to normal tissues.
  • To elucidate the functional role of STK4-AS1 in regulating osteosarcoma cell cycle progression and viability.
  • To explore the relationship between STK4-AS1 and the p53/p21 pathway in osteosarcoma.

Main Methods:

  • Comparative analysis of STK4-AS1, p53, and p21 expression in clinical osteosarcoma tissues and cell lines.
  • Functional assays involving overexpression and knockdown of STK4-AS1 in osteosarcoma (U2OS, MG63) and normal osteoblast (hFOB) cell lines.
  • Cell cycle analysis, cell viability assays, and Western blotting to assess protein expression (p53, p21, cyclins).

Main Results:

  • STK4-AS1 expression was elevated, while p53 and p21 expression was reduced in osteosarcoma samples.
  • STK4-AS1 knockdown in U2OS cells decreased viability, arrested the cell cycle at G0/G1, and increased p53/p21 levels.
  • Functional effects of STK4-AS1 were dependent on p53 expression, with MG63 cells (p53-null) showing no significant changes.

Conclusions:

  • LncRNA STK4-AS1 promotes osteosarcoma cell cycle progression by inhibiting p53 expression.
  • STK4-AS1 acts as an oncogenic lncRNA in osteosarcoma, potentially through the p53/p21 pathway.
  • Targeting STK4-AS1 may offer a novel therapeutic strategy for osteosarcoma.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.7K